1. Home
  2. MNTK vs NNNN Comparison

MNTK vs NNNN Comparison

Compare MNTK & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Montauk Renewables Inc.

MNTK

Montauk Renewables Inc.

SELL

Current Price

$2.40

Market Cap

267.6M

Sector

Utilities

ML Signal

SELL

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

BUY

Current Price

$4.49

Market Cap

270.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
MNTK
NNNN
Founded
1980
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
267.6M
270.4M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
MNTK
NNNN
Price
$2.40
$4.49
Analyst Decision
Hold
Analyst Count
3
0
Target Price
★ $1.70
N/A
AVG Volume (30 Days)
★ 860.9K
151.2K
Earning Date
11-04-2026
10-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
N/A
Revenue
★ $176,382,000.00
N/A
Revenue This Year
$20.76
N/A
Revenue Next Year
$16.15
N/A
P/E Ratio
★ $146.00
$446.57
Revenue Growth
★ 0.37
N/A
52 Week Low
$1.07
$4.16
52 Week High
$3.28
$44.73

Technical Indicators

Market Signals
Indicator
MNTK
NNNN
Relative Strength Index (RSI) 47.35 29.31
Support Level $1.40 N/A
Resistance Level $2.73 $6.95
Average True Range (ATR) 0.27 0.57
MACD -0.05 -0.03
Stochastic Oscillator 15.69 10.55

Price Performance

Historical Comparison
MNTK
NNNN

About MNTK Montauk Renewables Inc.

Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: